• Vt. to get $1.1 million drug settlement
    November 17,2012
     

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In
    ROCKINGHAM — Wildlife will be celebrated at the 17th annual Herrick’s Cove Wildlife Festival... Full Story
    BURLINGTON — Vermont police say a Burlington man is charged with a hate crime after they say he... Full Story
    MONTPELIER — A working group created to determine if Vermont should try to buy more than a dozen... Full Story
    More Articles
  •  
     
    • MEDIA GALLERY 
    • VIDEOS
    • PHOTOS